Vivienne Marsh

852 total citations
5 papers, 648 citations indexed

About

Vivienne Marsh is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Vivienne Marsh has authored 5 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Vivienne Marsh's work include Melanoma and MAPK Pathways (4 papers), Cancer Mechanisms and Therapy (2 papers) and Computational Drug Discovery Methods (2 papers). Vivienne Marsh is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Cancer Mechanisms and Therapy (2 papers) and Computational Drug Discovery Methods (2 papers). Vivienne Marsh collaborates with scholars based in United States and Germany. Vivienne Marsh's co-authors include Tammie C. Yeh, Kevin M. Koch, Stefan Groß, James D. Winkler, Eli Wallace, Brian Hurley, Allison Marlow, Patrice A. Lee, Darin Smith and Josh Ballard and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Vivienne Marsh

5 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vivienne Marsh United States	5	445	220	164	106	77	5	648
Alan G. Olivero United States	13	312 0.7×	89 0.4×	200 1.2×	67 0.6×	62 0.8×	26	618
Martin Pass United Kingdom	16	551 1.2×	250 1.1×	212 1.3×	69 0.7×	97 1.3×	31	873
Mark S. Albom United States	19	470 1.1×	325 1.5×	404 2.5×	124 1.2×	190 2.5×	34	983
Christoph M. Dehnhardt United States	18	641 1.4×	135 0.6×	312 1.9×	103 1.0×	84 1.1×	22	938
Todd Miller United States	4	267 0.6×	139 0.6×	179 1.1×	47 0.4×	107 1.4×	6	547
Stéphanie Blanchard Singapore	12	323 0.7×	166 0.8×	166 1.0×	33 0.3×	36 0.5×	29	548
Kimberly G. Petrov United States	8	288 0.6×	181 0.8×	277 1.7×	41 0.4×	50 0.6×	9	588
Asaad Nematalla United States	7	269 0.6×	123 0.6×	240 1.5×	35 0.3×	101 1.3×	13	547
James M. Hamby United States	17	542 1.2×	121 0.6×	349 2.1×	32 0.3×	30 0.4×	32	828
Marcel Koenig United States	11	281 0.6×	150 0.7×	121 0.7×	47 0.4×	26 0.3×	17	500

Countries citing papers authored by Vivienne Marsh

Since Specialization

Citations

This map shows the geographic impact of Vivienne Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivienne Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivienne Marsh more than expected).

Fields of papers citing papers by Vivienne Marsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivienne Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivienne Marsh. The network helps show where Vivienne Marsh may publish in the future.

Co-authorship network of co-authors of Vivienne Marsh

This figure shows the co-authorship network connecting the top 25 collaborators of Vivienne Marsh. A scholar is included among the top collaborators of Vivienne Marsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivienne Marsh. Vivienne Marsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Lee, Patrice A., Eli Wallace, Allison Marlow, et al.. (2010). Abstract 2515: Preclinical Development of ARRY-162, A Potent and Selective MEK 1/2 Inhibitor. Cancer Research. 70(8_Supplement). 2515–2515. 28 indexed citations

2.

Yeh, Tammie C., Vivienne Marsh, Bryan A. Bernat, et al.. (2007). Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor. Clinical Cancer Research. 13(5). 1576–1583. 442 indexed citations

3.

Eary, C. Todd, Robert D. Groneberg, Laurence E. Burgess, et al.. (2007). Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(9). 2608–2613. 74 indexed citations

4.

Wallace, Eli M., Joseph P. Lyssikatos, James F. Blake, et al.. (2005). Potent and Selective Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors. 1. 4-(4-Bromo-2-fluorophenylamino)-1- methylpyridin-2(1H)-ones. Journal of Medicinal Chemistry. 49(2). 441–444. 34 indexed citations

5.

Smith, Roger A., J A Barbosa, Mark A. Bobko, et al.. (2001). Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach. Bioorganic & Medicinal Chemistry Letters. 11(20). 2775–2778. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact